Table 2:

MRI features of ISCMs, per-lesion basis, total of 70 lesions in 49 patients

FeaturePrevalence
Location (n = 70)
    Cervical16 (23%)
    Cervicothoracic2 (3%)
    Thoracic40 (57%)
    Thoracic-conus1 (1%)
    Conus11 (16%)
Position (n = 62)
    Central23 (37%)
    Eccentric35 (56%)
    Exophytic4 (6%)
Morphology (n = 66)
    Well-circumscribed64 (97%)
    Ill-defined2 (3%)
Cord expansion (n = 70)
    Present44 (63%)
    Absent26 (37%)
Enhancement (n = 64)
    Present63 (98%)
    Absent1 (2%)
Enhancement pattern (n = 63)
    Homogeneous31 (49%)
    Heterogeneous31 (49%)
    Peripheral (ring)1 (2%)
Size of enhancing lesion, mm, mean (range)
    Anterior-posterior (n = 63)6.5 (1–16)
    Transverse (n = 53)7.3 (2–23)
    Superior-inferior (n = 63)19.9 (2–114)
Longitudinal extent, No. of vertebral segments, mean (range)
    Length of enhancement (n = 63)1.4 (1–8)
    Length of cord T2 signal hyperintensity (n = 69)4.5 (1–15)
    Ratio, T2 signal/enhancement (n = 63)3.6 (1–14)
T2 signal intensity (n = 70)
    Hyperintense55 (79%)
    Hypointense1 (1%)
    Isointense14 (20%)
T1 signal intensity (n = 63)
    Hyperintense10 (16%)
    Hypointense5 (8%)
    Isointense48 (76%)
Cystic change (n = 70)
    Intratumoral2 (3%)
    Peritumoral0 (0%)
Intratumoral hemorrhage (n = 70)1 (1%)